PROCEDURE
Time of OPU
OPU procedure either at 8 am or 8 pm
Status
Not yet recruiting
Phase
Not applicable
Enrollment
20
Locations
1
Results
Not posted
Publications
5
Study summary
Glucocorticoids and especially cortisol exhibit a pronounced diurnal variation. Levels peak around 8 am and may decrease around two to three times during the day reaching a nadir during the evening and early in the night. Ovulation has been described as a controlled inflammatory event. Following release of the oocyte, termination of the inflammatory reaction needs to take place in order for the follicle and the developing corpus luteum to avoid further damage. It has been suggested, that locally enhanced cortisol availability may play a role in limiting tissue damage and by acting as anti-inflammatory agents mediating repair and remodeling. The aim of the present study is evaluate the concentration of cortisol and cortisone in sets of serum and follicular fluid samples collected simultaneous and at different times of the day (8.00 a.m. and 8.00 p.m.) and compare the levels with the time of the day at which they are collected.
Interventions
PROCEDURE
OPU procedure either at 8 am or 8 pm
Timeline
First posted
Mar 14, 2025
Study start
Dec 30, 2026
Primary completion
Apr 30, 2027
Study completion
Dec 31, 2027
Results posted
Not reported
Registry updated
May 7, 2026
Outcomes
Evaluate the concentration of cortisol and cortisone in serum and follicular fluid samples collected at 8 am versus collection at 8 p.m.
Time frame · From enrollment to the end of treatment at 8 weeks
Evaluate the concentration of sex-steroids and cortisol metabolites in follicular fluid samples collected at 8 am versus collection at 8 p.m.
Time frame · From enrollment to the end of treatment at 8 weeks
Eligibility
Inclusion Criteria: * Indication for IVF / ICSI - treatment * Age ≥ 18 years and ≤ 35 years * Body weight: 19 - 29 kg/m2 * Ovarian reserve parameters in the adequate age - range, determined by Anti-Muellerian-Hormone (AMH) and Antral Follicle Count (AFC) (Shebl 2011, Hamdine 2015) * Regular cycle (25-35 days) Exclusion Criteria: * Age \< 18 years and \> 35 years * Body weight \< 60 kg and \> 90 kg * Ovarian reserve parameters outside the adequate age - range, determined by Anti-Muellerian-Hormone (AMH) and Antral Follicle Count (AFC) (Shebl 2011, Hamdine 2015) * Proven poor responder in preceding IVF-treatment-cycle, according to the Bologna criteria: at least two of the following three features must be present: (i) Advanced maternal age (≥40 years) or any other risk factor for POR (poor ovarian response) (ii) A previous POR (≤3 oocytes with a conventional stimulation protocol) (iii) An abnormal ovarian reserve test (i.e. AFC \< 5-7 follicles or AMH \< 0.5 -1.1 ng/ml) * Two episodes of POR after maximal stimulation are sufficient to define a patient as a poor responder in the absence of advanced maternal age or abnormal ORT * Diagnosis of polycystic ovarian syndrome (PCOS), according to Rotterdam criteria * Endometriosis stage 3 or 4 AFS (American Fertility Society) * Irregular cycle (\< 25 days and \> 35 days) * Treatment with GnRH-analogues during the previous 6 months * Intake of contraceptive pill (OCP) or any hormonal treatment during the last 3 months
Study locations
United Arab Emirates. Showing up to 24 locations stored in the fast local snapshot.
ART Fertility Clinics LLC
Abu Dhabi, United Arab Emirates
Publications
Related trials
Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita) · Infertility, Female · Ovulation Induction
Early Phase 1
Not yet recruiting
189
2026-07
University of Delaware · Estrogen · Premenopause
Phase 4
Recruiting
30
2026-07
Fundación Santiago Dexeus Font · Infertility
Phase 4
Completed
110
2026-04
Instituto Bernabeu · IVF
Phase 4
Completed
150
2026-03
Hanoi Medical University · Infertility (IVF Patients) · Embryo Morphokinetics
Not applicable
Recruiting
148
2026-02
University Hospital, Ghent · Ovarian Stimulation · Quality of Life
Phase 4
Recruiting
60
2025-12
Tam Anh TP. Ho Chi Minh General Hospital · Diminished Ovarian Reserve
Not applicable
Recruiting
730
2025-12
Jagiellonian University · Fibrin Blood Clot · Infertility, Female
Not applicable
Recruiting
300
2025-12
Related PeptideStat pages
Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.